BioNTech SE (BNTX) Reports Q2 EPS of EUR6.45
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/28/2026
- Wall Street ends higher on revived AI momentum
- Meta's $97.5B AI money grab: why Zuckerberg is racing to raise cash before rivals
- Deutsche Bank’s Reid sees potential final dip this year before Santa rally
- UPS tops estimates as efficiency drive gains momentum
- GM to move stock listing to Nasdaq in November, shares gain
Tweet
Share
E-mail
Get Alerts BNTX Hot Sheet
Join SI Premium – FREE
BioNTech SE (NASDAQ: BNTX) reported Q2 EPS of EUR6.45. Revenue for the quarter came in at EUR3.2 billion.
The company reiterated BioNTech COVID-19 2022 vaccine revenue guidance of €13 billion to €17 billion.
For earnings history and earnings-related data on BioNTech SE (BNTX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Orion Marine Group (ORN) Tops Q3 EPS by 3c ; Offers Guidance
- Pacific Valley Bank (PVBK) Tops Q3 EPS by 24c
- Christopher & Banks (CBK) Tops Q3 EPS by 79c
Create E-mail Alert Related Categories
Corporate News, Earnings, Hot EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
